Prime Medicine, Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

1.305

-0.035 (-2.61%)

May 13, 2025, 12:33 PM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '20 Dec 31, 2020
Genetic Therapies	2.98M	Log In
Genetic Therapies Growth	-42.74%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '20 Dec 31, 2020
United States	2.98M	Log In
United States Growth	-42.74%	Log In